<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d1 20130915//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="methods-article" dtd-version="1.1d1">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>Biomedical Research and Therapy</journal-title>
      </journal-title-group>
      <issn pub-type="epub" publication-format="electronic">2198-4093</issn>
      <publisher>
        <publisher-name>BioMedPress</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.15419/bmrat.v4i05.167</article-id>
      <article-categories>
        <subj-group subj-group-type="display-channel">
          <subject>Methodology</subject>
        </subj-group>
        <subj-group subj-group-type="heading">
          <subject>Biomedical Research and Therapy</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Quantification of angiogenic characteristics of Naproxen sodium through chorioallantoic membrane assay</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Muhammad Shoaib Zahid</surname>
            <given-names>Hafiz</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Ahmed Khan</surname>
            <given-names>Tanveer</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="corresp" rid="cor1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ijaz-ul-Haq</surname>
            <given-names>Muhammad</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Riaz</surname>
            <given-names>Humayun</given-names>
          </name>
          <xref ref-type="aff" rid="aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Atif Raza</surname>
            <given-names>Syed</given-names>
          </name>
          <xref ref-type="aff" rid="aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mohy-ud-din Khan</surname>
            <given-names>Zia</given-names>
          </name>
          <xref ref-type="aff" rid="aff2"/>
        </contrib>
        <aff id="aff1">
          <institution>Faculty of Pharmacy, Hajvery University, Lahore-Pakistan</institution>
        </aff>
        <aff id="aff2">
          <institution>Rashid Latif College of Pharmacy, Lahore-Pakistan</institution>
        </aff>
        <aff id="aff3">
          <institution>University College of Pharmacy, University of the Punjab, Lahore-Pakistan</institution>
        </aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1"><label>*</label>For correspondence: <email>tanveerahmedkhan754@gmail.com</email></corresp>
        <fn fn-type="con" id="equal-contrib">
          <label>*</label>
          <p>These authors contributed equally to this work</p>
        </fn>
      </author-notes>
      <pub-date date-type="pub" publication-format="electronic">
        <day>20</day>
        <month>05</month>
        <year>2017</year>
      </pub-date>
      <volume>4</volume>
      <issue>5</issue>
      <fpage>1</fpage>
      <lpage>2</lpage>
      <history>
        <date date-type="received">
          <day>25</day>
          <month>04</month>
          <year>2017</year>
        </date>
        <date date-type="accepted">
          <day>02</day>
          <month>05</month>
          <year>2017</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright: &#169; The Author(s) 2017</copyright-statement>
        <copyright-year>2017</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/CC-BY/4.0">
          <license-p>This article is published with open access by BioMedPress (BMP), Laboratory of Stem Cell Research and Application, Vietnam National University, Ho Chi Minh city, Vietnam This article is distributed under the terms of the Creative Commons Attribution License (CC-BY 4.0) which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.</license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:href="http://www.bmrat.org/index.php/BMRAT/article/view/167/493"/>
      <abstract>
        <p>Introduction: The aim of the current study was to determine the angiogenic/anti-angiogenic effect of Naproxen Sodium and to determine the effective dose of NapS for angiogenesis.</p>
        <p>Method: Fertilized eggs (5days old) of chicken were acquired from a local hatchery. They were incubated at 37&#176;C with humidity of 55-60%. Then, on the 5th day of incubation, a window about 2cm in diameter was created by removing the shell and then the inner shell membrane. It was done under aseptic environment. There were 5 groups designed. Group A was kept as control and was given 0.2ml PBS, group B, C, D, and E were given 0.1ml of 0.086g/100&#956;l, 0.042g/100&#956;l, 0.021g/100&#956;l and 0.011g/100&#956;l of Naproxen Sodium (NapS) respectively. On the sixth day, prepared concentrations of NapS were administered and eggs were again sealed with paraffin film under aseptic conditions. These were placed back in the incubator for next 24 hours. After 24 hours, eggs were taken out from the incubator and images of all groups were made using a DSL camera. The development of blood vessels and other features were observed using Adobe Photoshop version 7.0, then these images were transferred to scan probing image processing (SPIP) software 6.6.2. The diameters of different blood vessels were measured by using expert design software. The parameters include: the diameter and branching system of blood vessels measured as per mm, and categories of blood vessels; i.e., primary, secondary and tertiary blood vessels. Data were analyzed on SPSS statistical software version 22.0 using ANOVA. Dunnett&#8217;s test was applied considering P &lt; 0.05 as significant.</p>
        <p>Result: Application of Naproxen sodium on chorioallantoic membrane of day six of incubation showed angiogenic effects in high concentration and anti-angiogenic effect in low concentration. Outcomes indicated significant changes in CAM&#8217;s design, thinning of primary, secondary and tertiary blood vessels, reduction in surface roughness parameters, and decrease in Abbott curve. Conclusion: The substantial quantities of Naproxen sodium use locally may exhibit anti-angiogenic activity in the same manner those seen in vitro and explain its clinical efficacy.</p>
      </abstract>
      <kwd-group>
        <kwd>Angiogenesis</kwd>
        <kwd>Chorioallantoic membrane</kwd>
        <kwd>In vivo</kwd>
        <kwd>Naproxen sodium</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>Introduction</title>
      <p>The development of new blood vessels from pre-existing capillaries is termed as angiogenesis <xref ref-type="bibr" rid="ref4">Griffioen and Molema, 2000</xref>. This term angiogenesis (AG) was used in 1935 to define the development of new blood vessels in the placenta <xref ref-type="bibr" rid="ref5">Hertig, 1935</xref>. All cells and tissues survival are solely dependent on AG. Therefore, AG is extremely meaningful to different physiological functions like wound healing, menstruation, development of embryo and normal tissue growth <xref ref-type="bibr" rid="ref4">Griffioen and Molema, 2000</xref>. Physiologic AG involves many different pro- and anti-angiogenic stimuli including various environmental and growth factors <xref ref-type="bibr" rid="ref4">Griffioen and Molema, 2000</xref>. The AG switch is also observed as a distinct stage of cancer development, that occurs at any phase of tumor development and its micro-environment <xref ref-type="bibr" rid="ref2">Bergers and Benjamin, 2003</xref>. The use of anti-AG drugs for the management of AG established conditions have presented a lot of therapeutic potential. Numerous anti-AG medications are presently under development, involved in clinical trials or are being used in the treatment of AG complaints, mostly cancer <xref ref-type="bibr" rid="ref1">Abdollahi and Folkman, 2010</xref>. CAM model is used in the experiments in this study in order to test anti-angiogenic agents alone and in combination <xref ref-type="bibr" rid="ref8">Tufan and Satiroglu-Tufan, 2005</xref>. This model delivers a usual, in vivo setting of angiogenic blood vessels with all the multifaceted swarm communications on which angiogenic combinations can be verified <xref ref-type="bibr" rid="ref8">Tufan and Satiroglu-Tufan, 2005</xref>.</p>
      <p>Naproxen sodium is a non-steroidal anti-inflammatory drug (NSAID). It functions by decreasing hormones that provoke agony and soreness in the body. The aim of current research was to determine the angiogenic/anti-angiogenic effect of NapS and to determine the effective dose of NapS for angiogenesis.</p>
    </sec>
    <sec id="s2">
      <title>Materials - Methods</title>
      <sec id="s2-1">
        <title>Materials and Chemicals</title>
        <p>This study is based on the investigation of naproxen sodium. Naproxen sodium is purchased from Sigma-Aldrich (MO, Louis St, CA). Visualization of blood vessels are achieved through DSLR Camera. 0.9% NaCl solution, which is purchased from Searl Pakistan (Pvt.) Limited, is used as a solvent to make dilutions for drug or alone as a control. Injections into the CAM&#8217;s vasculature are achieved using a Microliter&#8482; syringes fortified with 33-G metal (N) needles.</p>
        <p>Fertilized eggs (5 days old) of chicken were purchased from a local hatchery. They were incubated at 37&#176;C with humidity of 55-60%. On the day five of incubation, an opening about 2cm in diameter was produced by eliminating the shell and then the innermost shell membrane. It was done under aseptic conditions. Approximately 4-5ml of albumin was detached and opening was airtight with paraffin film tape and was positioned back in the incubator.</p>
        <p>There were 5 groups designed. Group A was kept as control and was given 0.2ml phosphate buffer solution (PBS), group B, C, D, and E were given 0.1ml of 0.086g/100&#181;l (220 mg which is least effective dose in humans), 0.042 g/100&#181;l, 0.021 g/100&#181;l and 0.011 g/100&#181;l of Naproxen Sodium (NapS), respectively. At that point, pH of every one of these arrangements was checked with a pH meter and was acclimated to 6-7.4. Keeping in mind the end goal to decline the danger of tainting, all the readied weakenings were separated through 0.2&#181;m syringe channels. On the 6th day, the readied centralizations of NapS were directed and eggs were again fixed with paraffin film under aseptic conditions. These were set back in the hatchery for next 24 hours. Following 24 hours, eggs were taken out of hatchery and pictures of all groups i.e. control and also those treated with various convergences of NapS were made utilizing a DSL camera. The improvement of veins and different elements were watched utilizing Adobe Photoshop adaptation 7.0, then, these pictures were exchanged to filter testing picture handling programming SPIP 6.6.2. Individual x, y and z measurements of every picture were stacked to decide diverse parameters to evaluate angiogenesis. The widths of different veins were measured by utilizing adjustment and estimation command.</p>
      </sec>
      <sec id="s2-2">
        <title>Image-Processing Quantification (IPQ) Method</title>
        <p>IPQ is executed on images obtain from the DSL cameras using a macro written for SPIP (version 6.6.2) and existing plug-ins.</p>
        <p>The parameters reported describing the degree of inhibition of the naturally developing CAM include the diameter and branching system of blood vessels measured as per mm, and categories of blood vessels; i.e., primary, secondary and tertiary blood vessels.</p>
      </sec>
      <sec id="s2-3">
        <title>Statistical Analysis</title>
        <p>Data was assessed on SPSS statistical software version 22.0 using one way ANOVA. Dunnett&#8217;s Post Hoc test was applied considering P &lt; 0.05 as significant.</p>
      </sec>
    </sec>
    <sec id="s3">
      <title>Results</title>
      <sec id="s3-1">
        <title>Qualitative Analysis</title>
        <p>The inhibition of the physiologically-developing CAM is examined with Naproxen sodium (NapS). Exposure of the CAM with anti-AG compounds during the developmental phase characterized by exponential vascular growth prevents the regular growth of capillaries and vessels and directs the anti-angiogenic properties of the agents applied. The effects of this drug are visualized in <xref ref-type="fig" rid="fig1"> Figure 1 </xref>. It shows that NapS is angiogenic at higher concentration and anti-angiogenic at low concentrations.</p>
        <fig id="fig1">
          <label>Figure 1</label>
          <caption>
            <title>Angiogenesis with different concentration of NapS in all groups</title>
            <p>Group A is controlled with full development of blood vessels. However, anti-angiogenic phenomena in group B,C and D. Death of embryo in group E.</p>
          </caption>
          <graphic xlink:href="bmrat.v4i05.167/fig1.png"/>
        </fig>
      </sec>
      <sec id="s3-2">
        <title>Quantitative Analysis</title>
        <p>Quantitative analysis was done under three heads namely imaging studies, roughness analysis and diameter of blood vessels. These are discussed as below.</p>
      </sec>
      <sec id="s3-3">
        <title>Imaging studies</title>
        <p>The NapS was applied on CAM and images were captured at regular time intervals. The images captured were then analyzed with the software. These were transformed into three dimensional views of 45o as showed in <xref ref-type="fig" rid="fig2"> Figure 2 </xref>.</p>
        <fig id="fig2">
          <label>Figure 2</label>
          <caption>
            <title>Angiogenesis phenomena in 3D view at 45&#176;</title>
            <p>Group A is controlled with full development of blood vessels. However, anti-angiogenic phenomena in group B,C and D. Death of embryo in group E</p>
          </caption>
          <graphic xlink:href="bmrat.v4i05.167/fig2.png"/>
        </fig>
      </sec>
      <sec id="s3-4">
        <title>Roughness analysis</title>
        <p>There are no worldwide gauges for roughness investigation in light of surface pictures yet, however the actualized calculations are in assertion suggestions from driving specialists and a large portion of the definitions are regular augmentations of the ISO norms for surface profiles. With respect to all other expository outcomes the roughness parameters are composed of records, which can be transported in by worksheet suites and utilized for factual purposes. We also performed this parameter to check the roughness of images. Roughness of control and treated groups is given in  <xref ref-type="fig" rid="tab1"> Table 1 </xref>.</p>
        <fig id="tab1">
          <label>Table 1</label>
          <caption>
            <p>Shows roughness values</p>
          </caption>
          <graphic xlink:href="bmrat.v4i05.167/tab1.png"/>
        </fig>
        <p>For more accuracy, the control group revealed more roughness values than treated CAM. It indicates that surface roughness of treated CAMs was significantly less than control CAMs. The Abbott curve, a graphical representation of roughness, was also performed to calculate even slight alterations in the blood vessels heights on the CAM&#8217;s surface. The heights of the Abbott curve for control and treated CAMs were observed as showed in <xref ref-type="fig" rid="fig3"> Figure 3 </xref>.</p>
        <fig id="fig3">
          <label>Figure 3</label>
          <caption>
            <title>Abbott curves for roughness analysis</title>
            <p>Control group A indicating  more roughness and it is decreasing down from group B, C, D to E due to anti-angiogenic phenomena.</p>
          </caption>
          <graphic xlink:href="bmrat.v4i05.167/fig3.png"/>
        </fig>
      </sec>
      <sec id="s3-5">
        <title>Diameter of Blood Vessels</title>
        <p>The captured images were evaluated with the software to determine the vessel diameters. Different segments in a selected area for measurement were identified. The respective diameters of each vessel portion located in different segments were identified using the software. Utilizing this procedure, the diameter of a specific vessel was determined automatically at each time point for the respective drug concentration. The distribution of vessel diameter of the CAM was observed to be normal. From the results obtained, it was obvious that the vessel diameters of the CAM did not change significantly over time. It was also noted that in Group A and B diameter increased which shows that NapS increases diameter in higher concentrations. However, there is no significant statistical difference between both groups as P=0.010. On the other hand, in low concentrations, NapS worked as an anti-angiogenic agent and diameter of blood vessels decreased with a significant difference among control and treated groups (P=0.000) as showed in <xref ref-type="fig" rid="fig4"> Figure 4 </xref>.</p>
        <fig id="fig4">
          <label>Figure 4</label>
          <caption>
            <title>Diameter of group B (secondary blood vessel)</title>
            <p>Upper figure indicates the diameter of blood vessels in mm. Lower figure (graph) indicates the diameter of secondary blood vessel. i.e., 8mm.</p>
          </caption>
          <graphic xlink:href="bmrat.v4i05.167/fig4.png"/>
        </fig>
        <p>All the diameters of blood vessels in all treated and control groups with respect to their branching are summarized in <xref ref-type="fig" rid="tab2"> Table 2 </xref>.</p>
        <fig id="tab2">
          <label>Table 2</label>
          <caption>
            <p>Summarizes the diameters of blood vessels in all groups</p>
          </caption>
          <graphic xlink:href="bmrat.v4i05.167/tab2.png"/>
        </fig>
      </sec>
      <sec id="s3-6">
        <title>Branching Pattern of Blood Vessels</title>
        <p>The present study was also performed to investigate the development of blood vessels by the selection of a capillary plexus. To recognize this developmental process of blood vessels transformation, a series of photographs was recorded with a computer simulation of the process of in vivo vascularization. The simulation established that a positive feedback system contributed in the development of a branching pattern. As the embryo grew, it was witnessed that in Groups A and B, there was a fork branching pattern while in group C, D and E, there was polygonal and/or tree capillary networks as showed in <xref ref-type="fig" rid="fig5"> Figure 5 </xref>. An area where progress was rapidly received much blood flow and produced finer networks of capillaries.</p>
        <fig id="fig5">
          <label>Figure 5</label>
          <caption>
            <p>The figure shows the branching pattern in all groups</p>
          </caption>
          <graphic xlink:href="bmrat.v4i05.167/fig5.png"/>
        </fig>
      </sec>
    </sec>
    <sec id="s4">
      <title>Discussion</title>
      <p>The CAM model is widely used in angiogenic investigation and is principally appropriate  for  the  study  of  diseases  categorized  by  proliferative  retinal vasculature, such as age-related macular degeneration <xref ref-type="bibr" rid="ref8">Tufan and Satiroglu-Tufan, 2005</xref>. In the current effort, this model was used in order to determine the angiogenic and/or anti-angiogenic effect of Naproxen sodium (NapS) and determine the effective dose of NapS for angiogenesis.</p>
      <p>The effects of drug visualized in Figure 1 show that NapS is angiogenic at higher concentration and anti-angiogenic at low concentrations. Similar studies were conducted by Blacher et al. (2005) <xref ref-type="bibr" rid="ref3">Blacher et al., 2011</xref>. They used new advances  in  imaging  investigation  to  quantify  CAM  angiogenic  response, covering all vascular components, from the large supplying and feeding vessels down to the capillary plexus.  Their morphometric investigation highlighted that a precise quantification of the CAM vasculature desires to be executed at several scales <xref ref-type="bibr" rid="ref3">Blacher et al., 2011</xref>.</p>
      <p>Quantitative  analysis  was  performed  including  imaging  studies,  roughness analysis and diameter of blood vessels. The NapS was applied on CAM and images were captured at uniform time intervals. The images captured were then analyzed with the software. These were transformed into three dimensional views  as  shown  in <xref ref-type="fig" rid="fig2"> Figure 2 </xref>.  These  were  prepared  to  know  the  better understanding of blood vessels networks.</p>
      <p>There are no worldwide gauges for roughness investigation in light of surface pictures yet, however the actualized calculations are in assertion suggestions from driving specialists and a large portion of the definitions are regular augmentations of the ISO norms for surface profiles. With respect to all other expository outcomes the roughness parameters are composed to records, which can be transported in by worksheet suites and utilized for factual purposes. We also performed this parameter to check the roughness of images. These factors illuminate the variances in surface roughness between control and treated CAMs. The Abbott curve, a graphical picture of roughness, was also dignified to appraise even slight changes in the stature of blood vessels on the surface of CAMs. Abbott curve heights for control and treated CAMs were observed as shown in figure 3. This shows that roughness was found high in group A and B while in group C, D and E, roughness was comparatively low. Similarly, same roughness parameter was observed by Hussain et al. (2011) <xref ref-type="bibr" rid="ref6">Hussain, 2011</xref>. In their study, the average values of roughness in the control group were high in relation  to  treated  CAMs.  It  portrayed  that  surface  roughness  analysis, demonstrating neo-vascularization of treated CAMs was expressively (P&lt;0.05) less than that of control CAMs <xref ref-type="bibr" rid="ref6">Hussain, 2011</xref>.</p>
      <p>The captured images were assessed with the software to determine the vessel diameters.  Different  segments  in  a  selected  area  for  measurement  were identified. The respective diameters of each vessel portion located in distinct segments were identified using the software. Using this procedure, the diameter of a specific vessel was determined automatically at each time point for the respective drug concentration. The dispersal of the vessel diameter of the CAM was observed to be usual. From the investigations, it was obvious that the vessel diameters of the CAM did not modify meaningfully over time. It was also observed that in Group A and B diameter increased which shows that NapS increases diameter in higher concentrations. However, there is no significant statistical  difference  between  both  groups.  On  the  other  hand,  in  low concentrations, NapS worked as an anti-angiogenic agent and diameter of blood vessels decreased with a significant difference among control and treated groups (P=0.000) as shown in figure 4. Another study was conducted by Salas (2015) <xref ref-type="bibr" rid="ref7">Salas, 2015</xref> to assess the phytochemical components and properties of herbal plant extracts, such as Gynura nepalensis, Pandanus odoratissimus L. and Carmona retusa masam, as potential angiogenesis inhibitors using the CAM assay. They found similar reduction in diameter with Carmona retusa masam.</p>
      <p>The current research was also executed to investigate that blood vessels are fashioned  by  the  capillaries  selection  in  the  plexus.  To  recognize the developmental phenomena of blood vessel branching pattern, a series of radiographs was successfully recorded, and a computer simulation was carried out by the process of in vivo vascularization. The simulation established that a positive feedback system contributed in the development of a branching pattern. As the embryo grew, it was witnessed that in Groups A and B, there was a fork branching pattern while in group C, D and E, there was polygonal and/or tree capillary networks as shown in <xref ref-type="fig" rid="fig5"> Figure 5 </xref>. An area where progress was rapidly received much blood flow and produced finer networks of capillaries.</p>
    </sec>
    <sec id="s5">
      <title>Conclusion</title>
      <p>It is concluded that the presentation of Naproxen sodium on CAM on 6th day of incubation showed angiogenic effects in high concentration and anti-angiogenic effect in low concentration. Results indicated noticeable modifications in CAM design, weakening of blood vessels, reduction in surface roughness parameters, and decrease in Abbott curve. The significant amounts of Naproxen sodium may reveal anti-angiogenic activity in the similar fashion as those seen in vitro and describe its clinical efficacy.</p>
    </sec>
    <sec id="s6">
      <title>Abbreviations</title>
      <p>AG: Angiogenesis</p>
      <p>CAM: Chorioallantoic membrane</p>
      <p>NapS: Naproxen sodium</p>
      <p>SPSS: Statistical package for social sciences</p>
    </sec>
    <sec id="s7">
      <title>Author's contribution</title>
      <p>Hafiz Muhammad Shoaib Zahid conducted the research, Tanveer Ahmed Khan performed data analysis, Muhammad Ijaz-ul-Haq drafted the manuscript, Humayun Riaz reviewed the manuscript, Syed Atif Raza supervised the study, and Zia Mohy-ud-din Khan performed graphical interpretation.</p>
    </sec>
  </body>
  <back>
    <ack id="ack">
      <title>Acknowledgements</title>
      <p>We are grateful to Dr. Lubna Shakir, Komal Najam and Dr. Ovais Omer for their support and co-operation.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="ref1">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>A.</surname>
              <given-names>Abdollahi</given-names>
            </name>
            <name>
              <surname>J.</surname>
              <given-names>Folkman</given-names>
            </name>
          </person-group>
          <article-title>Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy</article-title>
          <source>Drug Resistance Updates</source>
          <year>2010</year>
          <volume>13</volume>
          <fpage>16</fpage>
          <lpage>28</lpage>
        </element-citation>
      </ref>
      <ref id="ref2">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>G.</surname>
              <given-names>Bergers</given-names>
            </name>
            <name>
              <surname>L.E.</surname>
              <given-names>Benjamin</given-names>
            </name>
          </person-group>
          <article-title>Tumorigenesis and the angiogenic switch</article-title>
          <source>Nature reviews cancer</source>
          <year>2003</year>
          <volume>3</volume>
          <fpage>401</fpage>
          <lpage>410</lpage>
        </element-citation>
      </ref>
      <ref id="ref3">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>S.</surname>
              <given-names>Blacher</given-names>
            </name>
            <name>
              <surname>L.</surname>
              <given-names>Devy</given-names>
            </name>
            <name>
              <surname>R.</surname>
              <given-names>Hlushchuk</given-names>
            </name>
            <name>
              <surname>E.</surname>
              <given-names>Larger</given-names>
            </name>
            <name>
              <surname>N.</surname>
              <given-names>Lamand&#233;</given-names>
            </name>
            <name>
              <surname>P.</surname>
              <given-names>Burri</given-names>
            </name>
            <name>
              <surname>P.</surname>
              <given-names>Corvol</given-names>
            </name>
            <name>
              <surname>V.</surname>
              <given-names>Djonov</given-names>
            </name>
            <name>
              <surname>J.-M.</surname>
              <given-names>Foidart</given-names>
            </name>
            <name>
              <surname>A.</surname>
              <given-names>No&#235;l</given-names>
            </name>
          </person-group>
          <article-title>Quantification of angiogenesis in the chicken chorioallantoic membrane (CAM)</article-title>
          <source>Image Analysis &amp; Stereology</source>
          <year>2011</year>
          <volume>24</volume>
          <fpage>169</fpage>
          <lpage>180</lpage>
        </element-citation>
      </ref>
      <ref id="ref4">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>A.W.</surname>
              <given-names>Griffioen</given-names>
            </name>
            <name>
              <surname>G.</surname>
              <given-names>Molema</given-names>
            </name>
          </person-group>
          <article-title>Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation</article-title>
          <source>Pharmacological reviews</source>
          <year>2000</year>
          <volume>52</volume>
          <fpage>237</fpage>
          <lpage>268</lpage>
        </element-citation>
      </ref>
      <ref id="ref5">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>A.T.</surname>
              <given-names>Hertig</given-names>
            </name>
          </person-group>
          <article-title>Angiogenesis in the early human chorion and in the primary placenta of the macaque monkey</article-title>
          <source>Contrib Embryol</source>
          <year>1935</year>
          <volume>25</volume>
          <fpage>39</fpage>
          <lpage>81</lpage>
        </element-citation>
      </ref>
      <ref id="ref6">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>I.</surname>
              <given-names>Hussain</given-names>
            </name>
            <name>
              <surname>M.O.</surname>
              <given-names>Omer</given-names>
            </name>
            <name>
              <surname>M.</surname>
              <given-names>Ashraf</given-names>
            </name>
            <name name-style="given-only">
              <given-names>Habib-Ur-Rehmanm</given-names>
            </name>
          </person-group>
          <article-title>Effect of diclofenac sodium angiogenesis using chorioallantoic membrane (cam) assay</article-title>
          <source>Journal of applied pharmacy</source>
          <year>2011</year>
          <fpage>320</fpage>
          <lpage>330</lpage>
        </element-citation>
      </ref>
      <ref id="ref7">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>G.M.</surname>
              <given-names>Salas</given-names>
            </name>
            <name>
              <surname>E.V.</surname>
              <given-names>Totaan</given-names>
            </name>
          </person-group>
          <article-title>Selected Philippine Herbal plant extracts as Angiogenesis inhibitors using Chick Chorioallantoic Membrane (CAM) assay</article-title>
          <source>International Research Journal of Biological Sciences</source>
          <year>2015</year>
          <fpage>28</fpage>
          <lpage>32</lpage>
        </element-citation>
      </ref>
      <ref id="ref8">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>A.C.</surname>
              <given-names>Tufan</given-names>
            </name>
            <name>
              <surname>N.L.</surname>
              <given-names>Satiroglu-Tufan</given-names>
            </name>
          </person-group>
          <article-title>The chick embryo chorioallantoic membrane as a model system for the study of tumor angiogenesis, invasion and development of anti-angiogenic agents</article-title>
          <source>Current cancer drug targets</source>
          <year>2005</year>
          <volume>5</volume>
          <fpage>249</fpage>
          <lpage>266</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>